MYC

May 23, 2017May 23, 2017

Stem Cell Transplants May Not Extend Survival in DHL Patients in Remission, UPenn Study Suggests

News

Undergoing autologous stem-cell transplantation (autoSCT) after achieving remission does not extend remission or survival in patients with double hit lymphoma (DHL) — an aggressive form of B-cell non-Hodgkin lymphoma characterized by ... Read more

February 14, 2017

New Oral Drug Shows Promise in Halting Growth of B-Cell Lymphoma Tumors

News

By simultaneously inhibiting two proteins that cancer cells need to survive, researchers offer a potentially promising therapeutic approach to treat B-cell lymphomas, according to a new study. CUDC-907, a new oral ... Read more

November 18, 2016

Epstein-Barr Virus Promotes Lymphoma by Taking Control of 2 Key Genes, Study Finds

News

Epstein-Barr virus, which causes mononucleosis, can also cause lymphoma by taking control of two genes involved in blood cancers and switching them on or off, a new study reported. The study, “MYC activation and ... Read more

November 10, 2016November 10, 2016

Defects in Molecular Controls for Key Immune Cell May Be Behind Onset of Blood Cancers

News

Immune cells triggered to fight an infection have two distinct and controlling internal clocks — one determines the amount of time such a cell has to divide, and the other determines how long the ... Read more

May 12, 2016May 12, 2016

Gene Regulator, RUNX1, Seen to Promote Lymphoma Progression Even at Normal Levels

News

A specific gene regulator called RUNX1 promotes the survival and proliferation of lymphoma cells even when expressed at normal levels or with normal activity, according to the study “Addiction to Runx1 is ... Read more

April 22, 2016April 22, 2016

Cyclacel Releases Promising Preclinical Data on Potential B-Cell Lymphoma Drug, Is Enrolling Patients for Phase 1 Study

News

Cyclacel Pharmaceuticals disclosed promising preclinical results of its drug candidate, CYC065, for the treatment of B-cell lymphoma in a poster presentation at the recent American Association for Cancer Research (AACR) annual meeting ... Read more

May 14, 2015May 14, 2015

Researchers Discover New Potential Therapeutic Strategy to Inhibit Lymphoma Development

News

A new study led by researchers at the A*STAR (Agency for Science, Technology and Research) in Singapore and the National University of Singapore discovered that blocking a specific cellular machinery ... Read more